ArticleCureus2022

Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus.

Bikash R Meher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.